AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 23227155 — intervention group
Group type: COMPARATOR
Intervention: Both AER and RES
Number of subjects: 25
Study 20219763 — intervention group
Group type: COMPARATOR
Intervention: Vitamin D intervention (placebo control)
Number of subjects: 2668
Study 20219763 — intervention group
Group type: EXPERIMENTAL
Intervention: Seasonal variation adjustment
Number of subjects: 2668
Study 20219763 — intervention group
Group type: EXPERIMENTAL
Intervention: Changes in weight, intake of vitamin D, and physical activity
Number of subjects: 2668
Study 17714465 — intervention group
Group type: EXPERIMENTAL
Intervention: AH Plus (G1)
Number of subjects: 100
Study 17714465 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulp Canal Sealer EWT (G2)
Number of subjects: 100
Study 17714465 — intervention group
Group type: EXPERIMENTAL
Intervention: RoekoSeal (G3)
Number of subjects: 100
Study 17714465 — intervention group
Group type: EXPERIMENTAL
Intervention: GuttaFlow (G4)
Number of subjects: 100
Study 17714465 — intervention group
Group type: COMPARATOR
Intervention: Negative control (intact crowns)
Number of subjects: 100
Study 17714465 — intervention group
Group type: COMPARATOR
Intervention: Positive control (not root filled)
Number of subjects: 100
Study 16335039 — intervention group
Group type: EXPERIMENTAL
Intervention: Human plasma perfusion
Number of subjects: 150
Study 16335039 — intervention group
Group type: COMPARATOR
Intervention: Physiologic saline perfusion
Number of subjects: 150
Study 16335039 — intervention group
Group type: EXPERIMENTAL
Intervention: Syntac/Tetric
Number of subjects: 150
Study 16335039 — intervention group
Group type: EXPERIMENTAL
Intervention: Solobond Plus/Arabesk
Number of subjects: 150
Study 16335039 — intervention group
Group type: EXPERIMENTAL
Intervention: Compoglass SCA/Compoglass
Number of subjects: 150
Study 11991216 — intervention group
Group type: EXPERIMENTAL
Intervention: perindopril 4 mg once daily (n = 42)
Number of subjects: 85
Study 11991216 — intervention group
Group type: EXPERIMENTAL
Intervention: losartan 50 mg once daily (n = 43)
Number of subjects: 85
Study 9655533 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefuroxime axetil 10 mg/kg twice daily for 5 days
Number of subjects: 520
Study 9655533 — intervention group
Group type: COMPARATOR
Intervention: Cefuroxime axetil 10 mg/kg twice daily for 10 days
Number of subjects: 520
Study 8732151 — intervention group
Group type: EXPERIMENTAL
Intervention: Bushenhuoxue Tablet (BSHX)
Number of subjects: 68
Study 8732151 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 68
Study 2652180 — intervention group
Group type: EXPERIMENTAL
Intervention: Pindolol
Number of subjects: 13
Study 2652180 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study 60029 — intervention group
Group type: EXPERIMENTAL
Intervention: Desoximetasone (0.25%)
Number of subjects: 30
Study 60029 — intervention group
Group type: COMPARATOR
Intervention: Hydrocortisone butyrate (0.1%)
Number of subjects: 30
Study 31621856 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress reduction (MBSR) adapted program
Number of subjects: 1
Study 30526053 — intervention group
Group type: EXPERIMENTAL
Intervention: Western instructors (WIs)
Number of subjects: 0
Study 30526053 — intervention group
Group type: COMPARATOR
Intervention: Nepalese instructor candidates (NICs)
Number of subjects: 0
Study 27515294 — intervention group
Group type: EXPERIMENTAL
Intervention: Meniett device (Medtronic Xomed)
Number of subjects: 129
Study 27515294 — intervention group
Group type: COMPARATOR
Intervention: Placebo device
Number of subjects: 129
Study 27797997 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic medication management (eMM) system implemented in paediatric wards, details on dosage and duration not specified.
Number of subjects: 0
Study 27797997 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified electronic medication management (eMM) system implemented in the second paediatric hospital, details on dosage and duration not specified.
Number of subjects: 0
Study 25428337 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjunctive Buchang Naoxintong Capsule (NXT)
Number of subjects: 90
Study 25428337 — intervention group
Group type: COMPARATOR
Intervention: Dual antiplatelet therapy (clopidogrel 75 g)
Number of subjects: 90
Study 22459724 — intervention group
Group type: EXPERIMENTAL
Intervention: Escitalopram 10 mg daily for four weeks
Number of subjects: 80
Study 22459724 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 20121658 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon beta‐1a (22 or 44 mcg three times weekly)
Number of subjects: 68
Study 20121658 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon beta‐1a (44 mcg)
Number of subjects: 68
Study 20121658 — intervention group
Group type: COMPARATOR
Intervention: Interferon beta‐1a (22 mcg)
Number of subjects: 68
Study 17540662 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac Resynchronization Therapy (CRT) implantation
Number of subjects: 469
Study 17540662 — intervention group
Group type: COMPARATOR
Intervention: Medical therapy
Number of subjects: 469
Study 17050262 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinician ratings on a battery of 10 neuropsychological tests
Number of subjects: 100
Study 17050262 — intervention group
Group type: EXPERIMENTAL
Intervention: Classification based on standard scores
Number of subjects: 100
Study 17050262 — intervention group
Group type: EXPERIMENTAL
Intervention: Global Deficit Scores (GDS)
Number of subjects: 100
Study 17050262 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinician ratings and deficit scores
Number of subjects: 100
Study 12598816 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetyl-L-carnitine (Alcar)
Number of subjects: 0
Study 12598816 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 10571496 — intervention group
Group type: EXPERIMENTAL
Intervention: Caring-based counseling
Number of subjects: 242
Study 10571496 — intervention group
Group type: EXPERIMENTAL
Intervention: Time passing
Number of subjects: 242
Study 8688344 — intervention group
Group type: EXPERIMENTAL
Intervention: PACEBOM
Number of subjects: 459
Study 8688344 — intervention group
Group type: COMPARATOR
Intervention: CHOP
Number of subjects: 459
Study 1992304 — intervention group
Group type: EXPERIMENTAL
Intervention: Solution A (rice-syrup solids)
Number of subjects: 86
Study 1992304 — intervention group
Group type: COMPARATOR
Intervention: Solution C (glucose-based solution, control)
Number of subjects: 86
Study 6340973 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucametacin (420 mg daily for 20 days)
Number of subjects: 30
Study 6340973 — intervention group
Group type: COMPARATOR
Intervention: Ketoprofen (300 mg daily for 20 days)
Number of subjects: 30
Study 30719536 — intervention group
Group type: EXPERIMENTAL
Intervention: Random Forest (RF)
Number of subjects: 126
Study 30719536 — intervention group
Group type: EXPERIMENTAL
Intervention: Neural Network (NN)
Number of subjects: 126
Study 30719536 — intervention group
Group type: EXPERIMENTAL
Intervention: Flexible Discriminant Analysis (FDA)
Number of subjects: 126
Study 28060040 — intervention group
Group type: EXPERIMENTAL
Intervention: Cysticidal therapy
Number of subjects: 500
Study 28060040 — intervention group
Group type: COMPARATOR
Intervention: Control group (no cysticidal therapy mentioned)
Number of subjects: 500
Study 28060040 — intervention group
Group type: EXPERIMENTAL
Intervention: Single lesion NCC
Number of subjects: 500
Study 28060040 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple lesion NCC
Number of subjects: 500
Study 26335906 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraplexus approach
Number of subjects: 26
Study 26335906 — intervention group
Group type: COMPARATOR
Intervention: Periplexus approach
Number of subjects: 26
Study 23369024 — intervention group
Group type: EXPERIMENTAL
Intervention: Celecoxib (200 mg/day)
Number of subjects: 10
Study 23369024 — intervention group
Group type: COMPARATOR
Intervention: Loxoprofen (180 mg/day)
Number of subjects: 10
Study 21368088 — intervention group
Group type: EXPERIMENTAL
Intervention: High spatial frequency (SF) gratings
Number of subjects: 0
Study 21368088 — intervention group
Group type: EXPERIMENTAL
Intervention: Low spatial frequency (SF) gratings
Number of subjects: 0
Study 19587472 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen 500 mg, three times a day for nine days
Number of subjects: 58
Study 19587472 — intervention group
Group type: EXPERIMENTAL
Intervention: Mesalamine 400 mg, three times a day for nine days
Number of subjects: 58
Study 17765438 — intervention group
Group type: EXPERIMENTAL
Intervention: Brimonidine‐purite 0.15%
Number of subjects: 90
Study 17765438 — intervention group
Group type: COMPARATOR
Intervention: Phenylephrine 1%
Number of subjects: 90
Study 17765438 — intervention group
Group type: COMPARATOR
Intervention: Sodium hyaluronate 0.1%
Number of subjects: 90
Study 15466785 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel plus cisplatin
Number of subjects: 152
Study 15466785 — intervention group
Group type: COMPARATOR
Intervention: Cyclophosphamide plus cisplatin
Number of subjects: 152
Study 11772973 — intervention group
Group type: EXPERIMENTAL
Intervention: Terlipressin (3 mg)
Number of subjects: 20
Study 11772973 — intervention group
Group type: EXPERIMENTAL
Intervention: Albumin (8 g/l of removed ascites)
Number of subjects: 20
Study 9882082 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexketoprofen trometamol 12.5 mg
Number of subjects: 210
Study 9882082 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexketoprofen trometamol 25 mg
Number of subjects: 210
Study 9882082 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexketoprofen trometamol 50 mg
Number of subjects: 210
Study 9882082 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoprofen 50 mg
Number of subjects: 210
Study 9882082 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 210
Study 8071037 — intervention group
Group type: EXPERIMENTAL
Intervention: iopromide (370 mg I/mL)
Number of subjects: 187
Study 8071037 — intervention group
Group type: COMPARATOR
Intervention: iopamidol
Number of subjects: 187
Study 8071037 — intervention group
Group type: COMPARATOR
Intervention: iohexol (350 mg I/mL)
Number of subjects: 187
Study 2650531 — intervention group
Group type: EXPERIMENTAL
Intervention: Visible light-activated, fluoride-releasing bonding system
Number of subjects: 22
Study 2650531 — intervention group
Group type: COMPARATOR
Intervention: Visible light-activated conventional bonding system
Number of subjects: 22
Study 241357 — intervention group
Group type: EXPERIMENTAL
Intervention: LF 17-895 (10 mg oral dose)
Number of subjects: 5
Study 241357 — intervention group
Group type: EXPERIMENTAL
Intervention: LF 17-895 (4 mg intravenous dose)
Number of subjects: 5
Study 241357 — intervention group
Group type: COMPARATOR
Intervention: Pindolol (comparison drug)
Number of subjects: 5
Study 29265891 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinomed® orthosis
Number of subjects: 34
Study 29265891 — intervention group
Group type: COMPARATOR
Intervention: Posture training support (PTS)
Number of subjects: 34
Study 27626368 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical treatment (Group 2)
Number of subjects: 62
Study 27626368 — intervention group
Group type: COMPARATOR
Intervention: Nonsurgical treatment (Group 1)
Number of subjects: 62
Study 26044218 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasotracheal suction mechanical ventilation treatment (test group)
Number of subjects: 53
Study 26044218 — intervention group
Group type: COMPARATOR
Intervention: Noninvasive positive pressure ventilation (CPAP) treatment (control group)
Number of subjects: 53
Study 23842830 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised exercise therapy (SET)
Number of subjects: 151
Study 23842830 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular revascularization (ER)
Number of subjects: 151
Study 21190037 — intervention group
Group type: EXPERIMENTAL
Intervention: 400(98%)
Number of subjects: 8
Study 21190037 — intervention group
Group type: EXPERIMENTAL
Intervention: 400(95%)
Number of subjects: 8
Study 21190037 — intervention group
Group type: EXPERIMENTAL
Intervention: 400(93%)
Number of subjects: 8
Study 19533210 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine
Number of subjects: 0
Study 19533210 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 17187274 — intervention group
Group type: EXPERIMENTAL
Intervention: A + HA group (arthroscopic knee joint lavage followed by 10 ml of 0.5% sodium hyaluronate)
Number of subjects: 80
Study 17187274 — intervention group
Group type: COMPARATOR
Intervention: Group A (arthroscopic knee joint lavage without hyaluronic acid)
Number of subjects: 80
Study 15006059 — intervention group
Group type: EXPERIMENTAL
Intervention: Transurethral resection of the prostate (TURP) plus sequential laparoscopic bladder diverticulectomy
Number of subjects: 25
Study 15006059 — intervention group
Group type: COMPARATOR
Intervention: Open bladder diverticulectomy and transvesical prostatectomy
Number of subjects: 25
Study 11557928 — intervention group
Group type: EXPERIMENTAL
Intervention: Noncontact normothermic wound therapy (3 treatments daily, dressing warmed to 38 degrees C for 1 hour)
Number of subjects: 40
Study 11557928 — intervention group
Group type: COMPARATOR
Intervention: Standard care (moisture retentive dressings providing absorption as needed)
Number of subjects: 40
Study 11398304 — intervention group
Group type: EXPERIMENTAL
Intervention: Migraineurs
Number of subjects: 50
Study 11398304 — intervention group
Group type: COMPARATOR
Intervention: Controls
Number of subjects: 50
Study 8143475 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed endotracheal suctioning
Number of subjects: 35
Study 8143475 — intervention group
Group type: COMPARATOR
Intervention: Open endotracheal suctioning
Number of subjects: 35
Study 8143475 — intervention group
Group type: EXPERIMENTAL
Intervention: Both methods
Number of subjects: 35
Study 2091073 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrendipine
Number of subjects: 111
Study 2091073 — intervention group
Group type: COMPARATOR
Intervention: Chlorthalidone
Number of subjects: 111
Study 2091073 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment (Nitrendipine + Chlorthalidone)
Number of subjects: 111
Study 792735 — intervention group
Group type: EXPERIMENTAL
Intervention: parsalmide
Number of subjects: 55
Study 792735 — intervention group
Group type: COMPARATOR
Intervention: phenylbutazone
Number of subjects: 55
Study 31730174 — intervention group
Group type: EXPERIMENTAL
Intervention: Spironolactone-pioglitazone-metformin (SPIOMET) for 1 year
Number of subjects: 31
Study 31730174 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral contraceptive (OC) for 1 year
Number of subjects: 31
Study 31730174 — intervention group
Group type: COMPARATOR
Intervention: Healthy age- and BMI-matched girls (Control)
Number of subjects: 31
Study 30938563 — intervention group
Group type: EXPERIMENTAL
Intervention: Consumer-decides (CD) approach to selecting hearing aids
Number of subjects: 40
Study 30938563 — intervention group
Group type: EXPERIMENTAL
Intervention: Audiology-based (AB) best practices trial
Number of subjects: 40
Study 30938563 — intervention group
Group type: COMPARATOR
Intervention: CD-based placebo device
Number of subjects: 40
Study 26976354 — intervention group
Group type: EXPERIMENTAL
Intervention: Current smokers
Number of subjects: 727
Study 26976354 — intervention group
Group type: COMPARATOR
Intervention: Non-smokers
Number of subjects: 727
Study 26333111 — intervention group
Group type: EXPERIMENTAL
Intervention: Handholding and spoken information (Experimental Group I)
Number of subjects: 94
Study 26333111 — intervention group
Group type: EXPERIMENTAL
Intervention: Handholding only (Experimental Group II)
Number of subjects: 94
Study 26333111 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 94
Study 26333111 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental Groups (I and II)
Number of subjects: 94
Study 24135894 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mg of avocado soybean unsaponifiables (ASU) for 3 months
Number of subjects: 14
Study 24135894 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 3 months
Number of subjects: 14
Study 21723697 — intervention group
Group type: EXPERIMENTAL
Intervention: RP-F
Number of subjects: 142
Study 21723697 — intervention group
Group type: COMPARATOR
Intervention: RP
Number of subjects: 142
Study 19261208 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent-delivered compensatory education intervention over 12 months
Number of subjects: 30
Study 19261208 — intervention group
Group type: COMPARATOR
Intervention: Control group (matched controls)
Number of subjects: 30
Study 19261208 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent-delivered compensatory education intervention
Number of subjects: 30
Study 18181513 — intervention group
Group type: EXPERIMENTAL
Intervention: Off-pump surgery
Number of subjects: 44
Study 18181513 — intervention group
Group type: COMPARATOR
Intervention: On-pump surgery
Number of subjects: 44
Study 15013959 — intervention group
Group type: EXPERIMENTAL
Intervention: 60% oxygen
Number of subjects: 204
Study 15013959 — intervention group
Group type: EXPERIMENTAL
Intervention: 40% oxygen
Number of subjects: 204
Study 15013959 — intervention group
Group type: COMPARATOR
Intervention: Air
Number of subjects: 204
Study 10923219 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin aspart (0.15 IU/kg body weight)
Number of subjects: 18
Study 10923219 — intervention group
Group type: COMPARATOR
Intervention: Human insulin (0.15 IU/kg body weight)
Number of subjects: 18
Study 10923219 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin aspart
Number of subjects: 18
Study 10923219 — intervention group
Group type: COMPARATOR
Intervention: Human insulin
Number of subjects: 18
Study 10923219 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin aspart and Human insulin
Number of subjects: 18
Study 8834979 — intervention group
Group type: EXPERIMENTAL
Intervention: New regimen with a crisis programme including a milieu therapeutic setting
Number of subjects: 38
Study 8834979 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 38
Study 1343612 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous sedation with 30 mg of pentazocine and 5 mg of diazepam
Number of subjects: 66
Study 1343612 — intervention group
Group type: COMPARATOR
Intervention: Hematoma block with 20 cc of 1.5% Xylocaine
Number of subjects: 66
Study 6364804 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimethoprim
Number of subjects: 75
Study 6364804 — intervention group
Group type: COMPARATOR
Intervention: Trimethoprim/sulfamethoxazole
Number of subjects: 75
Study 30523161 — intervention group
Group type: EXPERIMENTAL
Intervention: Diaphragm pacing intervention
Number of subjects: 39
Study 30523161 — intervention group
Group type: COMPARATOR
Intervention: Routine respiratory measures (VC, maximal inspiratory pressure, SNIP, twitch transdiaphragmatic pressure)
Number of subjects: 39
Study 30523161 — intervention group
Group type: EXPERIMENTAL
Intervention: Inspiratory capacity (IC)
Number of subjects: 39
Study 30523161 — intervention group
Group type: EXPERIMENTAL
Intervention: Supine fall in VC
Number of subjects: 39
Study 30523161 — intervention group
Group type: EXPERIMENTAL
Intervention: IC, SNIP, and functional residual capacity
Number of subjects: 39
Study 30055335 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive prolonged exposure therapy (exact details of dosage and duration not specified, but treatment is administered daily over a 3-week period)
Number of subjects: 0
Study 27019339 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional CBT for primary disorder
Number of subjects: 86
Study 27019339 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined CBT for both disorders
Number of subjects: 86
Study 23866103 — intervention group
Group type: EXPERIMENTAL
Intervention: Master Your Mood (MYM)
Number of subjects: 244
Study 23866103 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 244
Study 22085869 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-micronutrient supplementation
Number of subjects: 1388
Study 22085869 — intervention group
Group type: COMPARATOR
Intervention: Folic acid supplementation
Number of subjects: 1388
Study 22085869 — intervention group
Group type: COMPARATOR
Intervention: Iron-folic acid supplementation
Number of subjects: 1388
Study 19452699 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 4291
Study 19452699 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 4291
Study 19452699 — intervention group
Group type: EXPERIMENTAL
Intervention: Paroxetine
Number of subjects: 4291
Study 19452699 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram
Number of subjects: 4291
Study 19452699 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapoxetine
Number of subjects: 4291
Study 19452699 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvoxamine
Number of subjects: 4291
Study 17531725 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.7%-1.2% isoflurane
Number of subjects: 625
Study 17531725 — intervention group
Group type: EXPERIMENTAL
Intervention: 3.5%-5.5% desflurane
Number of subjects: 625
Study 17531725 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.2%-1.9% sevoflurane
Number of subjects: 625
Study 15090487 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 degrees head-down tilt (HDT)
Number of subjects: 0
Study 12079562 — intervention group
Group type: EXPERIMENTAL
Intervention: Etanercept (Enbrel)
Number of subjects: 11
Study 12079562 — intervention group
Group type: COMPARATOR
Intervention: Recombinant human interleukin 2 (rhIL-2)
Number of subjects: 11
Study 11013686 — intervention group
Group type: EXPERIMENTAL
Intervention: 50,000 IU urokinase instilled into the ventricles
Number of subjects: 21
Study 11013686 — intervention group
Group type: COMPARATOR
Intervention: Control group (no urokinase)
Number of subjects: 21
Study 7808223 — intervention group
Group type: EXPERIMENTAL
Intervention: Nerve growth factor (NGF) mRNA levels in Alzheimer's disease patients
Number of subjects: 0
Study 7808223 — intervention group
Group type: EXPERIMENTAL
Intervention: Poly (A)+ mRNA levels in Alzheimer's disease patients
Number of subjects: 0
Study 2698946 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril (25 mg twice a day)
Number of subjects: 11
Study 2698946 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine AR (20 mg twice a day)
Number of subjects: 11
Study 2698946 — intervention group
Group type: COMPARATOR
Intervention: Placebo (1 tablet twice a day)
Number of subjects: 11
Study 1043 — intervention group
Group type: EXPERIMENTAL
Intervention: Bu 1014 (8‐chloro‐1‐phenyl‐2,3,4,5‐tetrahydro‐1H‐1,5‐benzodiazepin‐2‐one)
Number of subjects: 0